DCM
STRO icon

Driehaus Capital Management’s Sutro Biopharma STRO Stock Holding History

Driehaus Capital Management’s Portfolio STRO Stock Details STRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7,970
Closed -$1.48M – 472
2021
Q2 		$1.48M Sell
7,970
-13,910
-64% -$2.72M 0.02% 329
2021
Q1 		$4.98M Sell
21,880
-4,180
-16% -$992K 0.07% 276
2020
Q4 		$5.66M Buy
26,060
+19,506
+298% +$3.23M 0.09% 239
2020
Q3 		$659K Hold
6,554
– – 0.01% 311
2020
Q2 		$509K Sell
6,554
-22,377
-77% -$2.15M 0.01% 314
2020
Q1 		$2.95M Buy
28,931
+838
+3% +$88.1K 0.1% 197
2019
Q4 		$3.09M Buy
28,093
+135
+0.5% +$13.9K 0.08% 240
2019
Q3 		$2.54M Buy
27,958
+567
+2% +$57.3K 0.08% 227
2019
Q2 		$3.12M Buy
27,391
+3,288
+14% +$362K 0.1% 201
2019
Q1 		$2.75M Sell
24,103
-8,918
-27% -$928K 0.1% 197
2018
Q4 		$2.98M Sell
33,021
-2,807
-8% -$339K 0.13% 182
2018
Q3 		$5.37M Buy
+35,828
New +$5.41M 0.17% 179

Other funds holding STRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

Driehaus Capital Management's STRO Position: Q3 2021 in Review

Driehaus Capital Management sold out of Sutro Biopharma (STRO) in Q3 2021, closing a stake of 7,970 shares — an estimated $1.48M sold.

Driehaus Capital Management first reported a position in STRO in Q3 2018 and held it in 12 quarters. The position peaked at $5.66M in Q4 2020. 120 funds tracked by Wall St. Rank hold STRO as of Q3 2021.

  • Driehaus Capital Management reported no remaining Sutro Biopharma position as of Q3 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 7,970 Sutro Biopharma shares in Q3 2021, an estimated $1.48M.
  • Driehaus Capital Management first reported a position in Sutro Biopharma in Q3 2018 and held it in 12 quarters.
  • Driehaus Capital Management's Sutro Biopharma position peaked at $5.66M in Q4 2020.
  • 120 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2021.

Based on Driehaus Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.